🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

13 recruiting trials

for Geographic Atrophy (GA)

SGLT2 Inhibitors in Geographic Atrophy NCT07174687Phase 21 site📍 St Louis Washington University School of Medicine · Tests: Dapagliflozin, Matching Placebo A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD) NCT06635148Phase 2, Phase 3104 sites📍 Tucson📍 Fullerton📍 La Jolla Janssen Research & Development, LLC · Tests: JNJ-81201887, Sham Procedure Central micrOperimetry and Radial OCT Evaluation in Geographic Atrophy (CORE-GA): a Prospective Pilot Study NCT07556406n/a1 site📍 San Francisco University of California, San Francisco · Tests: Optical coherence tomography, Microperimetry A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy NCT06541704Phase 3231 sites📍 Chandler📍 Phoenix📍 Phoenix Regeneron Pharmaceuticals · Tests: Pozelimab, Cemdisiran, Placebo A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA) NCT07144137n/a19 sites📍 Mountain View📍 Oak Forest📍 Springfield Complement Therapeutics Phase 2 Study of ADX-038 in Participants With Geographic Atrophy NCT06990269Phase 283 sites📍 Gilbert📍 Phoenix📍 Bakersfield ADARx Pharmaceuticals, Inc. · Tests: ADX-038, Placebo A Study to Evaluate the Safety and Effect of TO-O-1007 Intravitreal Implant in Subjects With Geographic Atrophy NCT07668804Phase 1, Phase 23 sites📍 Hurstville📍 Sydney📍 Launceston Theratocular Biotek Co. · Tests: TO-O-1007 (low-dose), TO-O-1007 (high-dose), Sham injection An Optimised GA Interventional Trial (Opti-GAIN) to Test if Treatment With CTx001 is Safe and Works for People With Geographic Atrophy (GA) NCT07392255Phase 1, Phase 28 sites📍 Carmel📍 Reno📍 Dallas Complement Therapeutics · Tests: CTx001 Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD NCT06659445Phase 2120 sites📍 Gilbert📍 Phoenix📍 Bakersfield ONL Therapeutics · Tests: ONL1204 Opthalmic solution, Avacincaptad Pegol intravitreal solution, Sham Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants NCT07230834Phase 19 sites📍 Lakewood📍 East Weymouth📍 Austin Regeneron Pharmaceuticals · Tests: Pozelimab A Phase 1/2 Study of the Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration NCT07029945Phase 1, Phase 217 sites📍 Gilbert📍 Phoenix📍 Hattiesburg Biojiva LLC · Tests: BRX011, Placebo A Phase 1/2 Study to Evaluate the Safety and Efficacy of Intravitreal Administration of BS01 in Patients With Geographic Atrophy Secondary to Dry AMD NCT07158775Phase 1, Phase 21 site📍 Edison Bionic Sight LLC · Tests: BS01, Sham procedure control Lesion-tailored, Fundus-controlled Perimetry in Geographic Atrophy (GA). NCT07582042n/a1 site📍 Salt Lake City University of Utah
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy